Supaveda · Ingredient Spotlight
Mustha
Cyperus rotundus L. — Nutgrass · Purple Nutsedge
Also known as: Musta · Mustaka · Nut Grass · Nagaramusta · Coco Grass · Java Grass · Xiangfu (TCM) · Cyperi Rhizoma · Sa'd Koofi
Every gardener in the world knows Cyperus rotundus by reputation — it is the most widespread weed on Earth, found on every continent except Antarctica, declared a problematic invasive on six. Ayurvedic physicians, classical Chinese herbalists, Arab physicians of the medieval Golden Age, traditional healers in Africa, South America, and South-East Asia all arrived at the same conclusion independently: this aggressive, unkillable sedge is also one of the most pharmacologically rich plants on the planet.
A perennial sedge of the Cyperaceae family, growing 10–75 cm tall in moist disturbed ground, waste lands, paddy margins, and roadsides from sea level to 1,800 metres elevation, C. rotundus is distinguished by its triangular stem, tufted grass-like leaves, and most importantly its small, fragrant, knobbly underground tubers — the medicinal part used across all traditional systems. A 2023 comprehensive review in Phytochemistry Reviews (PMC10183317) identified 552 compounds from C. rotundus — monoterpenoids, sesquiterpenoids, flavonoids, phenylpropanoids, triterpenoids, steroids, alkaloids, and more — making it one of the most phytochemically complex rhizomes in botanical medicine. 1 The same review confirmed pharmacological activities across neuroprotection, anti-inflammation, antipyresis, analgesia, sedation, gastroprotection, antidiarrhoea, anti-obesity, antidiabetes, and wound healing — every major disease category, from a plant most people spend their weekends trying to eradicate from their gardens.
🌿 The Weed That Heals the World — A Plant That Conquered Every Continent
Cyperus rotundus has the distinction of being both humanity's most studied agricultural pest and one of its oldest medicines — a duality that captures something profound about medicinal plants. Agricultural scientists describe it as the world's most problematic weed: it reproduces via rhizomes, tubers, and seeds simultaneously; its underground network can extend metres in all directions; it survives drought, flooding, tillage, and most herbicides; it has been found on every continent except Antarctica and in virtually every agricultural system on Earth. Entire research programmes exist devoted to eradicating it. 2
Yet across the same global distribution, every traditional medicine system that encountered this plant — Ayurveda in India, Traditional Chinese Medicine (where it is known as Xiangfu), Unani medicine in the Arab world, traditional healers in sub-Saharan Africa, folk practitioners in Brazil and Southeast Asia — all concluded not that it should be eliminated but that it should be harvested. The Charaka Samhita and Sushruta Samhita document Mustha as one of the primary herbs for fever (Jwaraghna), digestive normalisation (Deepana, Pachana, Grahi), and excessive thirst (Trushnanigraha). In Traditional Chinese Medicine, Cyperi Rhizoma is known as "the holy medicine of gynaecology" — the primary herb for menstrual irregularity, dysmenorrhoea, and liver qi stagnation — with over 500 patents issued in the past decade alone. The Egyptian traditional medicine used it for fever, renal colic, and sedation. In Brazil it treats respiratory conditions. In Thailand and the Philippines it is used for digestive and parasitic complaints. The plant's very unkillability — its capacity to survive and regenerate from even the smallest underground tuber fragment — seems to encode a biological resilience that classical physicians recognised as therapeutic potency.
The Ayurvedic name Mustha (also written Musta or Mustaka) comes from roots meaning "something that is held or grasped firmly" — possibly a reference to both the tenacious grip of the rhizome network underground, and the herb's firm grip on its therapeutic effectiveness. Classically it is the pratinidhi dravya (appointed substitute) for Ativisha (Aconitum heterophyllum) — an endangered, powerful anti-diarrhoeal and antipyretic herb — reflecting the classical pharmacist's recognition that Mustha's accessible, ubiquitous rhizomes share the core therapeutic actions of a much rarer and more difficult-to-source herb. 3
At a Glance — Key Evidence-Backed Benefits
Traditional Ayurvedic & Classical Uses
Mustha is documented across all major Ayurvedic texts from the Vedic period through to the classical pharmacopoeias — Charaka Samhita, Sushruta Samhita, Ashtanga Hridayam, Dhanvantari Nighantu, Raj Nighantu, and the Ayurvedic Pharmacopoeia of India. It appears in all three major classical herb groupings (Gana) that encompass its primary therapeutic roles: Mustadi Gana (the Musta group — digestive and carminative herbs), Lekhaneeya Mahakashaya (the obesity/ama-reducing group), and Jwaraghna Gana (the fever-relieving group). This triple classification reflects its exceptional versatility — simultaneously a digestive normaliser, a metabolic herb, and an antipyretic. 4
The classical description of Mustha as Sheeta Veerya (cooling potency) alongside its Tikta-Katu-Kashaya taste profile (bitter-pungent-astringent) defines its therapeutic character precisely: cooling for Pitta-driven inflammation and fever; bitter for liver-supported digestive normalisation and toxin clearance; astringent for its Grahi (absorptive-binding) effect in diarrhoea and intestinal inflammation; pungent for its digestive-fire (Agni) stimulating dimension. The cooling potency is pharmacologically unique in comparison with other digestive herbs like Sunthi (which is heating) — Mustha provides digestive stimulation and anti-inflammatory action without aggravating Pitta, making it the pre-eminent herb for hot, inflamed digestive conditions where warming herbs would worsen symptoms. 4
Ayurvedic Properties (Guna)
The Sheeta (cooling) potency is the defining pharmacological signature of Mustha. Most carminative and digestive herbs in Ayurveda are heating (Ushna) — ginger, black pepper, long pepper, cumin. Mustha is cooling yet still digestive-stimulating, which is pharmacologically unusual and clinically important: it is the herb of choice for inflammatory digestive conditions, Pitta-driven fevers, and hot, burning diarrhoea where heating herbs would aggravate. This cooling quality — combined with anti-inflammatory and antipyretic activities confirmed in modern pharmacology — makes it the essential Pitta-pacifying digestive herb in the classical Ayurvedic system.
Conditions Traditionally Treated
- Fever (Jwara) — the primary classical antipyretic herb; specifically Pitta-type fevers characterised by burning, excessive thirst, and inflammation; malarial fever particularly indicated in classical texts
- Diarrhoea, dysentery, and IBS (Grahani) — the primary Grahi herb; absorptive-binding properties reduce intestinal secretion; direct anti-enterotoxin activity confirmed against E. coli; carminative essential oils relieve cramping and bloating
- Excessive thirst (Trushnanigraha) — classical use for pathological thirst in fever and metabolic conditions; Pitta-reducing cooling action addresses the root cause of thirst in hot inflammatory states
- Digestive weakness with Pitta excess (Agnimandya with heat) — where warming herbs would worsen symptoms; the cooling digestive stimulant for hot, inflamed, burning digestive conditions
- Dysmenorrhoea and menstrual irregularity — spasmolytic action on uterine smooth muscle; TCM primary gynaecology herb; anti-inflammatory effect reduces prostaglandin-driven cramping
- Obesity and ama accumulation (Sthaulya) — in the classical Lekhaneeya Mahakashaya (fat-scraping) group; lipolytic activity confirmed; appetite centre modulation; metabolic normalisation
- Skin diseases (Kushtha) — anti-inflammatory, antioxidant, and antimicrobial for Pitta-driven skin conditions; wound healing activity confirmed
- Anxiety and nervous system heat (Vatavyadhi with Pitta) — sedative and anxiolytic activity in preclinical models; acetylcholinesterase inhibition; antidepressant activity; cooling the Pitta-heat of nervous system excess
- Liver conditions — hepatoprotective activity confirmed; polyphenols protect hepatocytes from oxidative stress; beta-sitosterol provides hepatic anti-inflammatory action
- Malaria — the classical fever herb with modern confirmation; in vivo antimalarial activity against Plasmodium berghei confirmed (Ounjaijean et al. 2024); the antipyretic dimension addresses malarial fever specifically
Key Active Compounds
The 552 compounds identified from C. rotundus include the full range of phytochemical classes — but the therapeutic identity of Mustha is anchored by its sesquiterpene profile (responsible for the distinctive fragrance and the primary spasmolytic, analgesic, and anti-inflammatory actions) and its flavonoid content (responsible for COX-2 inhibition, antioxidant, and antidiabetic actions). 1
Primary Bioactive Constituents
How Mustha Works — Four Core Mechanisms
Mustha's remarkable breadth — from fever to IBS to dysmenorrhoea to obesity — is explained by four intersecting mechanisms that together address the primary disease axes of Pitta and Kapha excess: inflammatory, digestive, smooth muscle, and metabolic. 12
Mustha's Four Core Therapeutic Mechanisms
What the Research Says
The most comprehensive characterisation of C. rotundus to date was published in Phytochemistry Reviews (Xue et al., 2023, PMC10183317) — a systematic review of all phytochemical, pharmacological, toxicological, and analytical literature on the plant, retrieved from PubMed, Google Scholar, SciFinder, ScienceDirect, Web of Science, and Chinese medical databases including CNKI and the Traditional Chinese Medicine Resource Network. 1 The review catalogued 552 compounds isolated or identified from C. rotundus, classified across: monoterpenoids, sesquiterpenoids (the dominant and most pharmacologically active class), flavonoids, phenylpropanoids, phenolics and phenolic glycosides, triterpenoids and steroids, diterpenoids, quinonoids, alkaloids, saccharides, and other compound classes.
The pharmacological summary confirmed activity across: neuroprotective (multiple studies), anti-inflammatory (Rocha et al. 2020), antipyretic (Deng et al. 2012), analgesic (Ahmad et al. 2012), sedative (Srivastava et al. 2013), anticonvulsant (Khalili et al. 2011), gastroprotective (Thomas et al. 2015), antidiarrhoeal (Uddin et al. 2006; Daswani et al. 2011), anti-cancer (multiple models), anti-obesity (Majeed et al. 2022), antioxidant (Khalili et al. 2011), antibacterial (Ahmad et al. 2012), anti-malarial (Thebtaranonth et al. 1995), antidiabetic (Singh et al. 2015), wound healing (Puratchikody et al. 2006), and antidepressant (Lin et al.) activity. The review also systematically compiled data mining on TCM prescriptions containing C. rotundus, confirming over 500 patents in the past decade. This breadth of pharmacological validation across multiple independent research teams and multiple continents provides the scientific basis for understanding why every traditional medical system that encountered this plant drew similar therapeutic conclusions.
A systematic review published in Frontiers in Pharmacology (Wang et al., 2022, doi: 10.3389/fphar.2022.965902) reviewed the ethnomedicine, phytochemistry, and pharmacology of Cyperi Rhizoma — the TCM designation for dried C. rotundus rhizome — described as the "holy medicine of gynaecology" in traditional Chinese medicine. 2 The review confirmed that its primary TCM indications include: soothing liver and relieving depression; regulating qi; regulating the menstrual cycle; and relieving pain — corresponding to Ayurvedic Pitta-reducing, digestive-normalising, and spasmolytic properties.
Modern pharmacological evidence confirmed across the review included: antioxidant, anti-inflammatory, antidepressant, antipyretic-analgesic, antitumour, hypoglycaemic, and antibacterial effects. The review noted that C. rotundus is used clinically in TCM for nervous system diseases (particularly depression and anxiety — qi stagnation conditions), cardiovascular conditions, digestive system diseases, uterine conditions, and as a general qi-regulating herb in complex formulas. The sheer scale of patented TCM formulations (500+ in the past decade) reflects the herb's foundational status in one of the world's largest traditional medicine systems — a pharmacological status earned across centuries of clinical observation and now receiving increasing scientific validation.
A 2024 study published in Advances in Pharmacological and Pharmaceutical Sciences (Ounjaijean et al., 2024, Wiley) evaluated the in vivo antimalarial activity of C. rotundus aqueous crude extract (CRE) and its combination with dihydroartemisinin (DHA) against Plasmodium berghei ANKA-infected mice — the standard experimental model for antimalarial drug testing. 5 The study used fresh rhizomes authenticated and voucher-deposited at Chiang Mai University (voucher NRU65/09-010), prepared as aqueous extract and evaluated at 100, 200, and 400 mg/kg in 4-day suppressive, curative, and prophylactic testing protocols.
Critically, the study confirmed no harmful effects and no mortality in acute and subacute toxicity testing on BALB/c mice at the doses evaluated — confirming safety alongside efficacy. The antimalarial activity was confirmed across all three testing protocols. CRE also reduced rectal temperature (antipyretic effect, directly relevant to the classical Jwaraghna indication for malarial fever) and increased mean survival time. The study also demonstrated synergistic activity when combined with dihydroartemisinin — potentially meaningful for combination antimalarial approaches. The anti-malarial sesquiterpene compounds of C. rotundus, including 10,12-peroxycalamenene (Thebtaranonth et al. 1995), are structurally distinct from artemisinin and operate through different mechanisms, providing a rational basis for the observed synergism.
A review published in Ancient Science of Life (PMC4484047) explored the pharmacology of Ativisha (Aconitum heterophyllum) and Musta (C. rotundus) as classical substitute-pair herbs (pratinidhi dravya) in Ayurveda. 3 The review confirmed that modern pharmacological studies validate the classical substitution: both species share antidiarrhoeal, antipyretic, anti-inflammatory, antihyperlipidaemic, and hypoglycaemic activities — pharmacologically justifying the classical decision to designate the abundant, accessible Musta as a substitute for the endangered Ativisha. The review specifically noted that both species share the key disease-relevant activities despite having entirely different phytochemical compositions and taxonomic classifications — illustrating the unique strength of Ayurvedic "pharmaco-taxonomy" (dravyaguna classification by biological function rather than chemical composition).
The antidiarrhoeal mechanism was further explored through a study by Daswani et al. on C. rotundus rhizome aqueous decoction against enteropathogenic and enterotoxigenic E. coli. While the decoction did not affect bacterial adherence, it produced significant inhibition of both labile toxin and stable toxin production — an inverse dose-response correlation where maximum inhibition of stable toxin was seen at 1:1000 dilution. This mechanism — directly neutralising bacterial enterotoxins rather than killing the bacteria — is pharmacologically significant and distinct from antibiotic approaches, with no risk of contributing to antibiotic resistance. The anti-inflammatory and antihyperlipidaemic activities confirmed in this review provide pharmacological support for the classical use of Musta in chronic metabolic and inflammatory conditions.
Mustha's classical inclusion in the Lekhaneeya Mahakashaya (the group of herbs that "scrape away" fat and excess Kapha) is supported by converging pharmacological evidence across multiple mechanisms. A study by Majeed et al. (2022) cited in the Xue et al. 2023 comprehensive review (PMC10183317) confirmed anti-obesity activity. 1 The proposed mechanisms are dual: alcoholic and aqueous extracts of the tubers exhibit lipolytic activity, directly promoting fat breakdown in adipose tissue; and compounds in C. rotundus release enhanced concentrations of biogenic amines from hypothalamic nerve terminals, suppressing the appetite centre through central neurotransmitter modulation — a mechanism analogous to how some pharmaceutical appetite suppressants work, through monoamine activity in the hypothalamus.
The antidiabetic dimension converges with the anti-obesity action: alpha-glucosidase inhibitors were isolated from C. rotundus using immobilised enzyme affinity screening combined with UHPLC-QTOF-MS (Deng et al. 2019), providing a direct mechanism for reducing post-meal blood glucose. An in vivo rat model showed 18% blood glucose reduction after 21 days of treatment. Quercetin's confirmed enhancement of pancreatic beta-cell insulin secretion adds an insulin-sensitising dimension. The combination of appetite suppression, lipolysis, reduced glucose absorption, and insulin sensitisation makes Mustha a multi-target metabolic herb — the modern pharmacological equivalent of the classical Lekhaneeya (fat-scraping) classification that Ayurvedic physicians arrived at through clinical observation.
Key Evidence at a Glance
Traditional Use & Modern Dosage
Mustha is used primarily as a decoction (Kwatha) or powder (Churna) in classical Ayurveda, where the rhizome tuber is the medicinal part. It appears in major classical compound formulas including Mustadi Kwatha, Shadangodaka (the classical fever-cooling formula), and as one of the primary ingredients in formulas for Jwara (fever) and Atisara (diarrhoea). The cooling, astringent, and carminative properties are best expressed in water-based preparations; the essential oil fraction (carrying the sesquiterpene spasmolytic compounds) requires some alcohol or oil extraction for full therapeutic activity.
| Form | Traditional Preparation | Typical Dose / Use |
|---|---|---|
| Musta Churna (Powder) | Dried, ground rhizome tuber powder; taken with warm water, buttermilk, or honey; the most fundamental and versatile preparation | 1–3 g twice daily; the standard Ayurvedic dose documented in classical pharmacopoeias; with warm water and honey for digestive use; with buttermilk for diarrhoea and IBS; with warm water after meals for anti-inflammatory and metabolic use |
| Musta Kwatha (Decoction) | Dried tuber pieces boiled in water (traditionally 1 part herb to 16 parts water, reduced to quarter volume); the classical preparation for fever and acute digestive conditions | 40–80 ml twice daily; the classical fever-management preparation in Shadangodaka; particularly effective for malarial and Pitta-type fevers; add jaggery or honey when cooled; the aqueous extraction maximises the anti-enterotoxin and antipyretic water-soluble fractions |
| Standardised Extract | Standardised C. rotundus extract (typically standardised to mustakone and/or essential oil content) | 250–500 mg standardised extract twice daily; take with warm water; the form providing the most consistent sesquiterpene content; preferred for digestive, spasmolytic, and metabolic applications where mustakone content is pharmacologically important |
| Mustadi Kwatha (Compound) | Classical compound decoction with Musta as the primary herb alongside complementary digestive herbs | Classical formula for IBS, chronic diarrhoea, and Grahani; Musta's Grahi (absorptive) and carminative properties are enhanced by companion herbs; prepared fresh and taken warm twice daily before meals |
| Shadangodaka (Fever Water) | The classical fever-management decoction: Musta, dried ginger, Parpata, Chandana, Ushira, Nagara — boiled and cooled; consumed as medicated water throughout the day during fever | Taken ad libitum as medicated water during febrile illness; Musta provides the cooling antipyretic dimension; Ushira and Chandana enhance the cooling; dried ginger provides the anti-microbial dimension; classical Ayurvedic equivalent of fever management fluid replacement |
| Topical (Oil/Paste) | Musta powder mixed with sesame oil or water to form a paste; applied to inflamed skin, joints, or for abdominal compresses in digestive spasm | Applied twice daily; anti-inflammatory and spasmolytic essential oils penetrate topically; classical wound-healing and anti-inflammatory skin application; abdominal paste application for colic and IBS cramping |
Supaveda Products with Mustha
Mustha provides the cooling Pitta-managing and digestive-normalising dimension in Supaveda's daily Rasayana and targeted formulas:
In the classical Chyawanprash tradition, Mustha provides the Pitta-pacifying digestive normaliser — the cooling counterbalance to the heating herbs like Sunthi, Pippali, and the warming adaptogens. Where Trikatu stokes the digestive fire with heat, Mustha provides that fire's Pitta-safe management: stimulating digestion without aggravating inflammatory heat. In Supa Life, Mustha's quercetin and kaempferol flavonoids contribute the COX-2 inhibitory anti-inflammatory dimension alongside Haridra's curcumin and Shallaki's AKBA — providing a third, complementary anti-inflammatory pathway at cooling potency. Its Lekhaneeya (fat-scraping) and metabolic-regulatory properties also contribute to the formula's weight management and metabolic normalisation dimension.
Safety & Precautions
Cyperus rotundus has an excellent traditional safety record with centuries of use across multiple cultures as both a food flavouring (the leaves are used in Middle Eastern and Southeast Asian cuisine) and a daily medicine. The 2024 antimalarial study (Ounjaijean et al.) confirmed no harmful effects or mortality in both acute and subacute toxicity testing in mice at therapeutic doses. Classical Ayurvedic texts document Musta as a generally safe herb with broad applicability. 5
Please Note
- Pregnancy: Mustha has emmenagogue properties (promotes menstrual flow) and spasmolytic action on uterine smooth muscle — both properties that warrant caution during pregnancy. Classical texts list it as potentially stimulating to uterine contractions at higher doses. Avoid therapeutic supplementation doses during pregnancy, particularly the first trimester, without professional guidance.
- Blood glucose medications: Confirmed hypoglycaemic activity (18% blood glucose reduction in animal models) means that those on insulin or oral antidiabetics should monitor blood glucose when beginning Mustha supplementation, as additive glucose-lowering effects are possible.
- Vata excess: Mustha's dry (Ruksha) and light (Laghu) qualities can increase Vata if taken long-term without ghee or oil as an anupana (carrier). Those with dry skin, constipation, or anxiety-type Vata conditions should take Musta with ghee or warm milk to counterbalance the drying quality.
- Quality and identification: Cyperus rotundus (Musta) should be distinguished from Cyperus scariosus (Nagaramusta) — a related but distinct species. Ensure products are botanically authenticated. The tuber (rhizome) is the medicinal part; aerial parts have different properties.
- Herb-drug interactions: The CNS-sedative properties of C. rotundus (confirmed sedative and anticonvulsant activity) suggest potential additive effects with sedatives, anxiolytics, or anticonvulsant medications. Those on these medications should consult their prescribing physician before supplementation.
Key Takeaways
Evidence-backed bullet points:
The world's most widespread weed is one of Ayurveda's most important medicines — found on every continent except Antarctica, declared invasive in six, yet simultaneously used medicinally by every traditional culture that encountered it. Independent convergence of therapeutic conclusions across India, China, Egypt, Arabia, Africa, Brazil, and Southeast Asia
Jwaraghna — the primary fever herb: α-cyperone inhibits the same PGE2-mediated hypothalamic fever pathway as paracetamol; antimalarial sesquiterpenes confirmed; in vivo antimalarial activity against P. berghei confirmed (Ounjaijean et al. 2024) with synergism with dihydroartemisinin and no toxicity at therapeutic doses
Sheeta — the cooling digestive: the only major Ayurvedic carminative and digestive-stimulating herb that simultaneously cools Pitta. While ginger and black pepper kindle digestive fire with heat, Mustha stimulates digestion without aggravating inflammatory heat — essential for hot, burning digestive conditions where warming herbs would worsen symptoms
552 compounds identified — one of the most phytochemically complex rhizomes in botanical medicine (Xue et al. 2023, Phytochemistry Reviews); pharmacological activities confirmed across 15+ distinct disease categories from neuroprotection to anti-obesity by independent research teams on multiple continents
TCM "holy medicine of gynaecology": Cyperi Rhizoma is the primary menstrual-regulating herb in Traditional Chinese Medicine; over 500 patents in the past decade; mustakone spasmolytic action on uterine smooth muscle directly supports the classical dysmenorrhoea indication
Anti-enterotoxin, not antibiotic: C. rotundus aqueous decoction inhibits labile and stable toxin production in both EPEC and ETEC E. coli — addressing traveller's diarrhoea through enterotoxin neutralisation rather than bacterial killing; no risk of contributing to antibiotic resistance
Lekhaneeya — the fat-scraper: classical inclusion in the obesity-reducing Mahakashaya validated by lipolytic activity in adipose tissue, central appetite suppression via biogenic amine release (hypothalamic mechanism), α-glucosidase inhibition for blood glucose control, and antihyperlipidaemic β-sitosterol
Quercetin and kaempferol — selective COX-2 inhibition: the flavonoid fraction provides anti-inflammatory action via selective COX-2 inhibition (without COX-1-mediated gastric ulceration), alongside antioxidant, hepatoprotective, and antidiabetic activity — a pharmacological profile that explains the breadth of anti-inflammatory, metabolic, and tissue-protective applications
No harmful effects at therapeutic doses confirmed in acute and subacute toxicity testing (Ounjaijean et al. 2024); centuries of food and medicine use across six continents without documented toxicity. Key precautions: avoid therapeutic doses in pregnancy (uterine spasmolytic); monitor blood glucose with antidiabetics; use with ghee if Vata constitution is dry
References
- Xue, B.X., He, R.S., Lai, J.X. et al. (2023) 'Phytochemistry, data mining, pharmacology, toxicology and the analytical methods of Cyperus rotundus L. (Cyperaceae): a comprehensive review', Phytochemistry Reviews, 22, pp.1353–1398. PMC10183317. doi: 10.1007/s11101-023-09870-3. [552 compounds catalogued across all phytochemical classes; neuroprotective (Jebasingh 2014; Dabaghian 2015); anti-inflammatory (Rocha 2020); antipyretic (Deng 2012); analgesic (Ahmad 2012); sedative (Srivastava 2013); anticonvulsant (Khalili 2011); gastroprotective (Thomas 2015); antidiarrhoeal (Uddin 2006; Daswani 2011); anti-cancer (Saad 2018; Susianti 2018); anti-obesity (Majeed 2022); antioxidant; antibacterial; antimalarial (Thebtaranonth 1995); antidiabetic (Singh 2015); wound healing; antidepressant; 500+ TCM patents confirmed; TCM prescription data mining; analytical methods comprehensive review].
- Wang, F., Zhang, S., Zhang, J. and Yuan, F. (2022) 'Systematic review of ethnomedicine, phytochemistry, and pharmacology of Cyperi Rhizoma', Frontiers in Pharmacology, 13, p.965902. doi: 10.3389/fphar.2022.965902. ["Holy medicine of gynaecology" TCM designation; soothing liver, relieving depression, regulating qi, regulating menstrual cycle, relieving pain — primary TCM indications; antioxidant, anti-inflammatory, antidepressant, antipyretic-analgesic, antitumour, hypoglycaemic, antibacterial confirmed; nervous system, cardiovascular, digestive, uterine clinical applications; distribution Western Asia (leprosy, thirst, fever, haematological), Egypt (expelling evil, diuresis, sedation, stomach pain), India (diabetes, arthritis, diarrhoea, dysentery, fever, dysmenorrhoea, blood diseases); Tao Hongjing classification; processing methods (fire, steam, milling) documented].
- PMC4484047 — 'Pharmacology of Ativisha, Musta and their substitutes', Ancient Science of Life. [Pratinidhi dravya (substitute) designation — Musta substitutes endangered Ativisha; both species share antidiarrhoeal, antipyretic, anti-inflammatory, antihyperlipidaemic, hypoglycaemic activities; pharmacological validation of substitution confirmed; Daswani et al. aqueous decoction vs EPEC and ETEC — labile and stable toxin inhibition confirmed; inverse dose-response for stable toxin inhibition; antidiarrhoeal mechanism via enterotoxin inhibition (not antibiotic); "pharmaco-taxonomy" — dravyaguna classification by biological function; C. scariosus (Nagaramusta) anti-inflammatory and antimicrobial confirmed].
- Patra, S. et al. (AYUSHDHARA) 'A review of medicinal properties on Musta (Cyperus rotundus Linn.)'. Also: JETIR February 2023, Vol. 10, Issue 2. [Tikta-Katu-Kashaya Rasa; Laghu-Ruksha Guna; Sheeta Veerya; Katu Vipaka; Kapha-Pittahara properties; Lekhaneeya Mahakashaya group (anti-obesity); Jwaraghna Gana (antipyretic); Sthoulyahara (obesity treatment); Deepana-Pachana-Grahi properties; Mustadi Gana; Shadangodaka formula; all classical indications documented — Jwara, Atisara, Trushnanigraha, Grahani, Artavadushti, Prameha, Kushtha, Sthaulya; Vedic period through classical pharmacopoeia documentation; Dhanvantari Nighantu, Raj Nighantu, Ayurvedic Pharmacopoeia of India; Kaseru classification; essential oil composition: Cyperene-2, β-selinene, Cyperenone, α-cyperone, Copadiene, Rotundone; chemical constituents including alkaloids, flavonoids, tannins, starch, glycosides, furochromones, sesquiterpenoids; copper, iron, magnesium, nickel, beta-sitosterol mineral and sterol content].
- Ounjaijean, S. et al. (2024) 'In vivo antimalarial activity of Cyperus rotundus and its combination with dihydroartemisinin against Plasmodium berghei', Advances in Pharmacological and Pharmaceutical Sciences. Wiley Online Library. doi: 10.1155/2024/6249977. [Aqueous crude extract (CRE); voucher NRU65/09-010 Chiang Mai University; 100, 200, 400 mg/kg; 4-day suppressive test; curative and prophylactic testing; PCV, BW, rectal temperature, MST measured; no harmful effects and no mortality in acute and subacute toxicity testing; antimalarial activity confirmed across all protocols; antipyretic effect (rectal temperature reduction); mean survival time increased; synergistic with dihydroartemisinin; anti-malarial sesquiterpenes Thebtaranonth et al. 1995 (10,12-peroxycalamenene) — structurally distinct from artemisinin; 2022 Frontiers systematic review Wang et al. cited as primary supporting evidence for broad pharmacological activity].